3
Shared Docs
1
Same-Page
3 / 3
Mentions
0:37:24 +0000 Have you heard of this colestrol Jul 24, 2015 @ 3:23 PM 1,169 views The FDA Approves A Potent And Pricey Cholesterol-Lowering Shot Matthew Herper , Forbes Staff I cover science and medicine, and believe this is biology's century. • Follow on Forbes (1970). • • • • • • Full Bio • Rece
ing a meeting convened by the FDA to analyze the data on the drug. Some doctors argued its use should be restricted mainly to patients with FH. But Mark Schoenebaum, Evercore ISI's pharmaceutical analyst, says that investors were initially disappointed because they had hoped the FDA would greenlight the drug for
rtance: — High Have you heard of this colestrol Jul 24, 2015 @ 3:23 PM 1,169 views The FDA Approves A Potent And Pricey Cholesterol-Lowering Shot Matthew Herper , Forbes Staff I cover science and medicine, and believe this is biology's century. ® Follow on Forbes (1970) e Full Bio e Recent Posts ° Popular
Page: HOUSE_OVERSIGHT_025888 →owing a meeting convened by the FDA to analyze the data on the drug. Some doctors argued its use should be restricted mainly to patients with FH. But Mark Schoenebaum, Evercore ISI’s pharmaceutical analyst, says that investors were initially disappointed because they had hoped the FDA would greenlight the drug for
Page: HOUSE_OVERSIGHT_025890 →layem <q wrote: Have you heard of this colestrol Jul 24, 2015 @ 3:23 PM 1,169 views The FDA Approves A Potent And Pricey Cholesterol-Lowering Shot Matthew Herper , Forbes Staff I cover science and medicine, and believe this is biology's century. e Follow on Forbes (1970) ° Full Bio ° Recent Posts ° Popular
Page: HOUSE_OVERSIGHT_026362 →owing a meeting convened by the FDA to analyze the data on the drug. Some doctors argued its use should be restricted mainly to patients with FH. But Mark Schoenebaum, Evercore ISI’s pharmaceutical analyst, says that investors were initially disappointed because they had hoped the FDA would greenlight the drug for
Page: HOUSE_OVERSIGHT_026364 →Entities connected to both Matthew Herper and Mark Schoenebaum
Regeneron
PERSON
Troy Brennan
PERSONLeonard S. Schleifer
PERSON
Geoffrey Porges
PERSONSchleifer
PERSON
Olivier Brandicourt
PERSON
CVS Caremark
ORGANIZATIONPraluent
ORGANIZATIONTarrytown
LOCATION
Jeffrey Epstein
PERSON
Pfizer
ORGANIZATION
Amgen
ORGANIZATION
John Brennan
PERSON
the Cleveland Clinic
ORGANIZATION
Sanford C. Bernstein
ORGANIZATIONNissen
PERSON
Donald Trump
PERSONVioxx
ORGANIZATION
The European
ORGANIZATION
Genzyme
ORGANIZATION